CDXSNasdaqIndustrial Organic ChemicalsFiscal year ends December 31

CODEXIS, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026

$1.32+0.08 (+6.45%)

Close on Oct 19, 2026

Market cap: $120.19M
P/E (TTM): –
Dividend yield: –

CODEXIS, INC. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31
Revenue	70	59	70	139	105	69	68	61	50	49	42	35	32	88	124	107	83
Cost of Revenue	9.34	16	13	38	22	14	16	13	14	9.75	6.59	9.73	15	31	42	28	17
Gross Profit	61	43	57	101	83	55	53	48	36	39	35	26	17	58	82	79	66
Research & Development	52	46	59	80	56	44	34	30	30	22	21	23	32	57	61	52	55
Selling, General & Admin	47	55	53	52	49	35	32	29	29	25	22	22	27	31	37	34	30
Advertising Expenses	0.10	0	0.30	0.30	0.30	0.30	0.50	0.50	0.70	0.50	0.30	0.30	0.50	0.40	0.11	0.06	–
Operating Expenses	–	–	–	–	–	–	–	72	73	57	–	54	73	119	140	114	101
Total Costs & Expenses	112	118	138	173	127	93	81	72	73	57	50	54	73	–	–	–	–
Operating Income	-42	-59	-68	-35	-23	-24	-13	-11	-23	-8.56	-7.77	-19	-41	-31	-16	-7.12	-18
Interest Expense	–	–	–	–	–	–	–	–	–	–	–	–	0.01	0	0	0.53	–
Interest & Investment Income	2.63	3.67	4.17	1.44	0.46	0.41	1.29	0.67	0.15	0.06	0.02	0.02	0.06	0.25	0.27	0.17	0.18
Other Non-Operating Income	-4.81	-10	-12	0.12	1.15	-0.16	-0.66	-0.29	-0.09	-0.09	–	–	–	–	–	–	–
Merger & Restructuring Charges	3.41	0	3.28	3.17	0	0	–	–	–	–	–	–	0.80	3.11	–	–	–
Asset Impairment Charges	0	0.17	9.98	0	0	0	0	0	0	0	0	0	0	0	–	–	–
Gain (Loss) on Investments	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.16	–	–
Gain (Loss) on Sale of Assets	–	–	–	–	–	–	0	-0.01	-0.01	0.04	-0.03	-0.02	0	-1.55	-0.05	-0.15	0.05
Pretax Income	-44	-65	-76	-33	-21	-24	-12	-11	-23	-8.60	-7.92	-19	-41	-31	-16	-8.16	-20
Income Tax Expense	0.05	0.03	0.07	0.28	0.19	0.34	0.02	-0.04	0.08	-0.04	-0.34	-0.26	-0.09	0.27	0.24	0.38	0.07
Net Income	-44	-65	-76	-34	-21	-24	-12	-11	-23	-8.56	-7.58	-19	-41	-31	-17	-8.54	-20
EPS (Basic)(per share)	-0.50	-0.89	-1.12	-0.51	-0.33	-0.40	-0.21	-0.21	-0.50	-0.21	-0.19	-0.50	-1.08	-0.84	-0.46	-0.35	-7.74
EPS (Diluted)(per share)	-0.50	-0.89	-1.12	-0.51	-0.33	-0.40	-0.21	-0.21	-0.50	-0.21	-0.19	-0.50	-1.08	-0.84	-0.46	-0.35	-7.74
Shares Outstanding (Basic, Weighted)(shares)	87	73	68	65	65	59	57	52	46	41	39	38	38	37	36	25	–
Shares Outstanding (Diluted, Weighted)(shares)	87	73	68	65	65	59	57	52	46	41	39	38	38	37	36	25	–
EBITDA	-36	-54	-63	-29	–	–	–	–	–	–	–	–	–	–	–	–	–
Provision for Credit Losses	–	–	0	0.05	0.34	0.04	0	–	–	–	–	–	–	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 87.0%
Operating margin: -35.6%
Net margin: -39.6%
Return on equity, FY2025: -74.9%

Financial strength

Current ratio: 3.06
Debt to equity: 1.24
Debt to assets: 34.0%
Cash to current liabilities: 115.6%

Valuation

P/E ratio: –
Price to sales: 1.55
Price to book: 3.65
Dividend yield: –